grant

Elucidating the innate and adaptive immune mechanism differences during viral myocarditis between pediatric and adult populations: role of sex, age and hormone status

Organization UNIVERSITY OF FLORIDALocation GAINESVILLE, UNITED STATESPosted 18 Jul 2024Deadline 31 May 2027
NIHUS FederalResearch GrantFY20250-11 years old0-4 weeks old21+ years oldAcute MyocarditisAdultAdult HumanAffectAgeAgingAndropauseAnimal ModelAnimal Models and Related StudiesAntibody ResponseAutoimmune DiseasesAutopsyBlood SampleBlood specimenCOVID infected patientCOVID patientCOVID positive patientCOVID-19 infected patientCOVID-19 patientCOVID-19 positive patientCOVID19 patientCOVID19 positive patientCardiac Failure CongestiveCardiac Muscle CellsCardiac MyocytesCardiac TransplantationCardiocyteCardiovascularCardiovascular Body SystemCardiovascular Organ SystemCardiovascular systemCausalityCause of DeathCell BodyCellsCessation of lifeChildChild YouthChildhoodChildren (0-21)ClinicalClinical DataComplementComplement ProteinsCongestive CardiomyopathyCongestive Heart FailureCoxsackie VirusesCoxsackievirusDataDeathDevelopmentDiagnosisDifferences between sexesDiffers between sexesDilated CardiomyopathyDiseaseDisorderDysfunctionElderlyEndocrine Gland SecretionEnterovirusEstrogensEtiologyFemaleFunctional disorderGoalsGonadal Steroid HormonesHeartHeart DecompensationHeart GraftingHeart Muscle CellsHeart TransplantationHeart VascularHeart failureHeart myocyteHormonesImmuneImmune Cell ActivationImmune MarkersImmune responseImmunesImmunologic MarkersIncidenceInfantInfectionInfectious AgentInflammasomeInflammationInflammatoryInnate Immune ResponseKnowledgeLaboratoriesLifeLiteratureMale Change of LifeMenopauseMiceMice MammalsMissionModelingMurineMusMyocardialMyocarditisMyocardiumNational Institutes of HealthNecrosisNecroticNewborn InfantNewbornsOutcomePathway interactionsPatient CarePatient Care DeliveryPatientsPersonalized medical approachPhysiopathologyPopulationPubertyPublic HealthReportingResearchRoleSARS-CoV-2 infected patientSARS-CoV-2 patientSARS-CoV-2 positive patientSeveritiesSeverity of illnessSex DifferencesSex HormonesSex Steroid HormonesSexual differencesSudden DeathTestingTestosteroneTherapeuticTherapeutic EstrogenTherapeutic HormoneTherapeutic TestosteroneTrans-TestosteroneUnited States National Institutes of HealthViral DiseasesVirus DiseasesVulnerable Populationsadaptive immune responseadult youthadulthoodadvanced ageage associatedage associated differenceage based differenceage correlatedage dependentage dependent differenceage dependent variationage differenceage linkedage relatedage related differenceage related variationage specificage specific differenceagedaged miceaged mouseagesautoimmune conditionautoimmune disorderautoimmunity diseasecardiac failurecardiac functioncardiac graftcardiac inflammationcardiac musclecardiomyocytecare for patientscare of patientscaring for patientscausationchild patientschronic heart failurecirculatory systemcomplementationcoronavirus disease 2019 infected patientcoronavirus disease 2019 patientcoronavirus disease 2019 positive patientcoronavirus disease infected patientcoronavirus disease patientcoronavirus disease positive patientcoronavirus disease-19 patientcoronavirus patientdevelopmentaldiffer by agedifference across agedifference in agedisease causationdisease severityelderly micefunction of the heartgeriatricgonadal steroidsheart functionheart muscleheart transplanthost responseimmune activationimmune system responseimmune-based biomarkersimmunological biomarkersimmunological markersimmunoresponseimprovedindividualized approachinfectious organisminnovateinnovationinnovativekidslife spanlifespanmalemodel of animalmouse modelmurine modelnecropsynewborn childnewborn childrenold miceovarian failurepathophysiologypathwaypatient infected with COVIDpatient infected with COVID-19patient infected with SARS-CoV-2patient infected with coronavirus diseasepatient infected with coronavirus disease 2019patient infected with severe acute respiratory syndrome coronavirus 2patient with COVIDpatient with COVID-19patient with COVID19patient with SARS-CoV-2patient with coronavirus diseasepatient with coronavirus disease 2019patient with severe acute respiratory distress syndrome coronavirus 2pediatricpediatric patientspersonalized approachpostmortemprecision approachpredictive biological markerpredictive biomarkerspredictive markerpredictive molecular biomarkerpreventpreventingresponsesenior citizensevere acute respiratory syndrome coronavirus 2 infected patientsevere acute respiratory syndrome coronavirus 2 patientsevere acute respiratory syndrome coronavirus 2 positive patientsexsex based differencessex steroidsex-dependent differencessex-related differencessex-specific differencessocial rolespecific biomarkerstailored approachvariation by agevascular inflammationviral infectionviral myocarditisvirally-induced myocarditisvirus infectionvirus-induced diseasevirus-induced myocarditisvulnerable groupvulnerable individualvulnerable peopleyoung adultyoung adult ageyoung adulthoodyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
Myocarditis is a leading cause of sudden death in children and young adults but is understudied, especially in

children. Viral myocarditis, inflammation of the heart muscle, has been found to involve both the innate and

adaptive immune response in adult myocarditis models, but before this study, there were no mouse models for

pediatric viral myocarditis; therefore, this is unstudied in the pediatric population. Our long-term goal is to

evaluate the development and progression of myocarditis, dilated cardiomyopathy, and heart failure across the

lifespan. Our overall objective of this application is to determine how the immune mechanisms differ between

pediatric and adult mice and patients leading to and during myocarditis. Our central hypothesis is that younger

pediatric mice and patients, before the onset of puberty, will develop a stronger innate and adaptive immune

response, leading to severe disease during myocarditis. This hypothesis will be tested with the following two

specific aims: 1) Identify the differences in immune biomarkers between pediatric and adult myocarditis

patients by sex and age. 2) Determine how age and hormone status alter the immune response, leading to

altered viral myocarditis severity in a translational mouse model by sex. Under the first aim, we will utilize 550

adult and pediatric patient blood samples/clinical data to investigate if patient age alters immune biomarkers

predicting disease severity based on cardiac function and/or standard laboratory values in myocarditis patients

by sex. For the second aim, we will first examine innate and adaptive immune mechanism differences

between pediatric and adult mice in myocarditis utilizing female and male 3-week, 4-week, and 8-week-old

mice. We will assess differences in the inflammasome, complement, and antibody response at 48, 5 days, and

10 days post-infection. Next, we will investigate the role of sex hormones in pediatric and adult mice to

determine if age differences are due to estrogen and testosterone changes during puberty and aging. We will

utilize gonadectomy at various ages to study the influence of hormones on innate and adaptive immune

responses in male and female mice. Additionally, we will utilize aged male mice and a VCD-induced ovarian

failure model in female mice to study the effect of menopause/andropause on myocarditis mechanisms. The

research proposed in this application is innovative because it departs from the status quo and studies the

differences between pediatric and adult mouse populations using the first pediatric viral myocarditis mouse

model. The proposed research is significant because it is expected to identify how the age of patients/mice

could influence the innate and adaptive immune response leading to myocarditis severity or progression. This

will have a positive impact as it is expected to significantly impact the myocarditis field by providing a

mechanistic understanding of how sex, age, and hormone status interplay in response to viral infection during

acute myocarditis and will lead to targeted treatments in an individualized manner and provide a better

understanding of pediatric disease.

Grant Number: 5R21AI180863-02
NIH Institute/Center: NIH

Principal Investigator: Katelyn Bruno

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →